![PDF] Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e207ba6f37118af9aaf8760412d727b65d24fe21/6-Figure4-1.png "PDF] Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. | Semantic Scholar")
PDF] Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. | Semantic Scholar
ABT-737 is a Selective and BH3 Mimetic Bcl-2, Bcl-xL and Bcl-w Inhibitor - Network of Cancer Research
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
Chemical structures of ABT-737 (left) and ABT-263 (right ). | Download Scientific Diagram
ABT-737 -
ABT-737 | ≥99%(HPLC) | Selleck | Bcl-2 阻害剤
Frontiers | BH3 Mimetics for the Treatment of Prostate Cancer
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
Rapid Detection of an ABT-737-Sensitive Primed for Death State in Cells Using Microplate-Based Respirometry | PLOS ONE
Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT- 737, through Regulating Mcl-1
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells | Leukemia
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized - ScienceDirect
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B | Cell Death & Disease
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized - ScienceDirect
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
Navitoclax - Wikipedia
![ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2013/144/1/fig-8-2x.jpg "ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]")
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B | Cell Death & Disease
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL | Journal of Experimental & Clinical Cancer Research | Full Text
ABT-737|Bcl-2 inhibitor|CAS# 852808-04-9 - APExBIO
Schematic summary of the effects of ABT-737 on human oral cancer cells.... | Download Scientific Diagram
Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT- 737, through Regulating Mcl-1
Mechanisms of potentiation of ABT-737 lethality by strategies targeting... | Download Scientific Diagram
